Valneva SE, a specialty vaccine company, announced it will report its first quarter 2026 consolidated financial results on May 13, 2026. The company will host a live webcast at 3 p.m. CET/9 a.m. ET to discuss the results and provide a business update, accessible on its website. Valneva focuses on developing vaccines for infectious diseases, including a Lyme disease vaccine candidate partnered with Pfizer. This update is important for investors tracking the company's progress and vaccine pipeline development.
FREELANDER International has revealed the dimensions of its first strategic model, the FREELANDER 8, a mid-to-large size SUV measuring 5,118 mm long, 2,050 mm wide, and 1,926 mm high. The vehicle combines British craftsmanship, intelligent technology...
Yorkville International Capital Corp. priced its initial public offering at $200 million, selling 20 million units at $10 each. The units will trade on Nasdaq's Global Market under the ticker YICCU starting June 16, 2026, with each unit comprising on...
Pepeto's presale has raised over $10.27 million and is preparing for a Binance listing amid a forming crypto bull run, promising strong potential gains similar to past Binance token launches. Meanwhile, Standard Chartered predicts XRP could reach $8 ...
Ready Capital Corporation announced quarterly cash dividends for Q2 2026. Common stockholders and Operating Partnership unit holders will receive $0.01 per share payable on July 31, 2026. Additionally, dividends of $0.390625 per share for Series C Pr...
Terra Innovatum Global filed its 2025 Annual Report on Form 10-K, marking its first full year as a public company. The company ended fiscal 2025 with $102.9 million in cash and no debt, supported by proceeds from its business combination with GSR III...
